Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions

Circulation Research

Volumn 116, Issue 7, 2015, Pages 1193-1201

  Van Belle, Eric ^a,b   Rauch, Antoine ^a,b   Vincentelli, André ^a,b   Jeanpierre, Emmanuelle ^a,b   Legendre, Paulette ^c   Juthier, Francis ^a,b   Hurt, Christopher ^a   Banfi, Carlo ^a,b   Rousse, Natacha ^a,b   Godier, Anne ^d   Caron, Claudine ^a,b   Elkalioubie, Ahmed ^a,b   Corseaux, Delphine ^a,b   Dupont, Annabelle ^b   Zawadzki, Christophe ^a,b   Delhaye, Cédric ^a   Mouquet, Frédéric ^a   Schurtz, Guillaume ^a   Deplanque, Dominique ^a   Chinetti, Giulia ^b   Staels, Bart ^b   Goudemand, Jenny ^a,b   Jude, Brigitte ^a,b   Lenting, Peter J ^c   Susen, Sophie ^a,b,e   more..

^a LILLE UNIVERSITY HOSPITAL   (France)

^b EGID ^*  (France)

^c Dept Environ Med Natl Inst Publ HIth   (Norway)

^d Fondation Carpentier   (France)

^e Centre Hospitalier Régional   (France)

Author keywords

Aortic valve stenosis; Blood flow velocity; Von Willebrand factor

Indexed keywords

POLYMER; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

AGED; ANIMAL MODEL; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; FEMALE; HUMAN; IN VITRO STUDY; MALE; MOLECULAR WEIGHT; NONHUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; RABBIT MODEL; SHEAR STRESS; THROMBOCYTE FUNCTION ANALYZER; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR ENDOTHELIUM; ANIMAL; AORTA VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BLOOD; BLOOD CLOTTING PARAMETERS; BLOOD FLOW VELOCITY; BLOOD RHEOLOGY; CHEMISTRY; COMPUTER SYSTEM; DISEASE MODEL; HEART ASSIST DEVICE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROCEDURES; PROSPECTIVE STUDY; PROTEIN MULTIMERIZATION; RABBIT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANIMALS; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; COMPUTER SYSTEMS; DISEASE MODELS, ANIMAL; FEMALE; HEART-ASSIST DEVICES; HEMORHEOLOGY; HUMANS; MALE; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; PROTEIN MULTIMERIZATION; RABBITS; TRANSCATHETER AORTIC VALVE REPLACEMENT; VON WILLEBRAND FACTOR;

EID: 84930705746     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.305046     Document Type: Article

References (27)

1. Leon MB, Smith CR, Mack M, PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607. doi: 10.1056/NEJMoa1008232.
2. Van Belle E, Juthier F, Susen S, FRANCE 2 Investigators Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation 2014; 129: 1415-1427. doi: 10.1161/CIRCULATIONAHA.113.002677.
3. Khawaja MZ, Sohal M, Valli H, Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era. Catheter Cardiovasc Interv 2013; 81: 366-373. doi: 10.1002/ccd.24534.
4. Loscalzo J, From clinical observation to mechanism-Heyde's syndrome. N Engl J Med 2012; 367: 1954-1956. doi: 10.1056/NEJMcibr1205363.
5. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B, Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008; 33: 679-684. doi: 10.1016/j.ejcts.2007.12.047.
6. Le Tourneau T, Susen S, Caron C, Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction. Circulation 2008; 118: 1550-1557. doi: 10.1161/CIRCULATIONAHA.108.786681.
7. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M, Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010; 3: 675-681. doi: 10.1161/CIRCHEARTFAILURE.109.877597.
8. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D, Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010; 56: 1207-1213. doi: 10.1016/j.jacc.2010.05.016.
9. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE, Subcommittee on von Willebrand Factor Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 2000 84 345 349
10. Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Trummer G, Berchtold-Herz M, Schlensak C, Zieger B, Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Eur J Cardiothorac Surg 2011 40 1328 1333; discussion 1233. doi: 10.1016/j.ejcts.2011.03.021.
11. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B, Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343-349. doi: 10.1056/NEJMoa022831.
12. Solomon C, Budde U, Schneppenheim S, Czaja E, Hagl C, Schoechl H, von Depka M, Rahe-Meyer N, Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery. Br J Anaesth 2011; 106: 494-500. doi: 10.1093/bja/aeq413.
13. Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA, Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 2009; 324: 1330-1334. doi: 10.1126/science.1170905.
14. Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D, Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998 91 1325 1331
15. Blackshear JL, Wysokinska EM, Safford RE, Thomas CS, Stark ME, Shapiro BP, Ung S, Johns GS, Chen D, Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study). Am J Cardiol 2013; 111: 374-381. doi: 10.1016/j.amjcard.2012.10.015.
16. Assad RS, Cardarelli M, Abduch MC, Aiello VD, Maizato M, Barbero-Marcial M, Jatene A, Reversible pulmonary trunk banding with a balloon catheter: assessment of rapid pulmonary ventricular hypertrophy. J Thorac Cardiovasc Surg 2000 120 66 72
17. Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM, Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study. J Thromb Haemost 2007; 5: 244-249. doi: 10.1111/j.1538-7836.2007.02320.x.
18. Ben-Dor I, Pichard AD, Satler LF, Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc Interv 2010; 3: 1150-1156. doi: 10.1016/j.jcin.2010.08.014.
19. Kappetein AP, Head SJ, Généreux P, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012; 60: 1438-1454. doi: 10.1016/j.jacc.2012.09.001.
20. Tsai HM, Sussman II, Nagel RL, Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994 83 2171 2179
21. Ott HW, Griesmacher A, Schnapka-Koepf M, Golderer G, Sieberer A, Spannagl M, Scheibe B, Perkhofer S, Will K, Budde U, Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection. Am J Clin Pathol 2010; 133: 322-330. doi: 10.1309/AJCPZSBTD2BWOMVL.
22. Dong JF, Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost 2005; 3: 1710-1716. doi: 10.1111/j.1538-7836.2005.01360.x.
23. Pareti FI, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, Ruggeri ZM, Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000 102 1290 1295
24. van Mourik JA, Boertjes R, Huisveld IA, Fijnvandraat K, Pajkrt D, van Genderen PJ, Fijnheer R, von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999 94 179 185
25. Xiong Y, Hu Z, Han X, Jiang B, Zhang R, Zhang X, Lu Y, Geng C, Li W, He Y, Huo Y, Shibuya M, Luo J, Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways. Cell Res 2013; 23: 820-834. doi: 10.1038/cr.2013.56.
26. Nombela-Franco L, Rodés-Cabau J, DeLarochellière R, Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv 2012; 5: 499-512. doi: 10.1016/j.jcin.2012.02.010.
27. Lenting PJ, Casari C, Christophe OD, Denis CV, von Willebrand factor: the old, the new and the unknown. J Thromb Haemost 2012; 10: 2428-2437. doi: 10.1111/jth.12008.